clenbuterol has been researched along with Kidney Failure, Chronic in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartung, R | 1 |
| Gerth, J | 1 |
| Fünfstück, R | 1 |
| Gröne, HJ | 1 |
| Stein, G | 1 |
1 other study available for clenbuterol and Kidney Failure, Chronic
| Article | Year |
|---|---|
End-stage renal disease in a bodybuilder: a multifactorial process or simply doping?
Topics: Adrenergic beta-Agonists; Adult; Anabolic Agents; Clenbuterol; Doping in Sports; Exercise; Humans; K | 2001 |